COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology
Review
[키워드] ACE
acute respiratory syndrome
administration
affecting
albumin
Alter
assist
association
Cancer
cancer patient
Cancer patients
caused
condition
contribute
coronavirus
Coronavirus disease 2019
COVID
COVID-19
COVID-19 vaccine
distribution
effective
effective vaccine
Effective vaccines
Efficacy
exacerbated
faster
global pandemic
highlighting
immune system
Immunocompromised
immunocompromised individuals
Immunocompromised patient
implementation
Interaction
lack
limitation
Lipid nanoparticles
mechanism
mortality rate
mRNA vaccine
Nanomaterial
Nanotechnology
Neutrophils
pandemic
Patient
personalised
Pharmaceutics
Prevalence
required
SARS-CoV-2
show
the vaccine
Treatment
Vaccine
Vaccine development
vaccine platform
viral spike protein
viral strains
Viral vector
virus
[DOI] 10.1016/j.intimp.2020.107247 PMC 바로가기 [Article Type] Review
[DOI] 10.1016/j.intimp.2020.107247 PMC 바로가기 [Article Type] Review